A carregar...
Ixazomib promotes CHOP-dependent DR5 induction and apoptosis in colorectal cancer cells
Background: Ixazomib (Ninlaro), a novel proteasome inhibitor, has been developed for the treatment of many cancers and has demonstrated anti-tumor efficacy against various malignancies. However, the mechanism of the anti-tumor effect of ixazomib in colorectal cancer (CRC) cells remains unclear. Meth...
Na minha lista:
| Publicado no: | Cancer Biol Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6370389/ https://ncbi.nlm.nih.gov/pubmed/30359552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529095 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|